ArticleFrontiers in immunology2022

Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors.

Rebekka Mispelbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.